MedTrace Logo

Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention

NCT04081051 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17294

Last updated 2023-12-05

No results posted yet for this study

Summary

This study aims to evaluate clinical outcomes and antibiotic prescription patterns following the use of diagnostic algorithms, point of care (PoC) rapid diagnostic tests, and behaviour change interventions in cases of acute febrile illnesses in children, adolescents and adults presenting at out patient clinics in lower and middle income countries. The study is to be implemented in 2 phases- the first run from 2020 to 2021 and the 2nd phase from 2021 to 2022 to include COVID-19 PoCTs.

Conditions

  • Acute Febrile Illness

Interventions

OTHER

diagnostic algorithm+Point of care rapid diagnostic tests+ Behavior change ( assessed together as a single package of interventions)

Diagnostic algorithm utilizing pathogen specific and non-pathogen specific point of care, rapid diagnostic tests, behavioral change intervention for healthcare workers

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • Indian Council of Medical Research

    collaborator OTHER_GOV

  • WHO, Special Programme for Research and Training in Tropical Diseases (TDR)

    collaborator UNKNOWN

  • Foundation for Innovative New Diagnostics, Switzerland

    lead OTHER

Principal Investigators

  • Piero Olliaro, MD · Foundation for Innovative New Diagnostics (FIND)

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-31
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Burkina Faso
  • Ghana
  • India
  • Nepal
  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04081051 on ClinicalTrials.gov